Literature DB >> 22515555

Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling.

Khaled Abduljalil1, Penny Furness, Trevor N Johnson, Amin Rostami-Hodjegan, Hora Soltani.   

Abstract

BACKGROUND: Pregnancy is associated with considerable changes in the physiological, anatomical and biochemical attributes in women. These may alter the exposure to xenobiotics between pregnant and non-pregnant women who receive similar doses, with implications for different susceptibility to environmental pollutants or therapeutic agents. Physiologically based pharmacokinetic (PBPK) models together with in vitro in vivo extrapolation (IVIVE) of absorption, distribution, metabolism and excretion (ADME) characteristics may capture the likely changes. However, such models require comprehensive information on the longitudinal variations of PBPK parameter values; a set of data that are as yet not available from a singular source. AIM: The aim of this article was to collect, integrate and analyse the available time-variant parameters that are needed for the PBPK modelling of xenobiotic kinetics in a healthy pregnant population.
METHODS: A structured literature search was carried out on anatomical, physiological and biochemical parameters likely to change in pregnancy and alter the kinetics of xenobiotics. Collated data were carefully assessed, integrated and analysed for trends with gestational age. Algorithms were generated to describe the changes in parameter values with gestational age. These included changes in maternal weight, the individual organ volumes and blood flows, glomerular filtration rates, and some drug-metabolising enzyme activities.
RESULTS: Articles were identified using relevant keywords, quality appraised and data were extracted by two investigators. Some parameters showed no change with gestational age and for others robust data were not available. However, for many parameters significant changes were reported during the course of pregnancy, e.g. cardiac output, protein binding and expression/activity of metabolizing enzymes. The trend for time-variant parameters was not consistent (with respect to direction and mono-tonicity). Hence, various mathematical algorithms were needed to describe individual parameter values.
CONCLUSION: Despite the limitations identified in the availability of some values, the collected data presented in this paper provide a potentially useful singular resource for key parameters needed for PBPK modelling in pregnancy. This facilitates the risk assessment of environmental chemicals and therapeutic drug dose adjustments in the pregnant population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22515555     DOI: 10.2165/11597440-000000000-00000

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  343 in total

1.  Comparative placental structure.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-06-14       Impact factor: 15.470

2.  Heartburn of pregnancy.

Authors:  D H Van Thiel; J S Gavaler; S N Joshi; R K Sara; J Stremple
Journal:  Gastroenterology       Date:  1977-04       Impact factor: 22.682

3.  CARDIOVASCULAR HEMODYNAMICS IN PREGNANCY. I. BLOOD AND PLASMA VOLUMES IN MULTIPLE PREGNANCY.

Authors:  J J ROVINSKY; H JAFFIN
Journal:  Am J Obstet Gynecol       Date:  1965-09-01       Impact factor: 8.661

4.  New aspects of breast volume measurement using 3-dimensional surface imaging.

Authors:  Laszlo Kovacs; Maximilian Eder; Regina Hollweck; Alexander Zimmermann; Markus Settles; Armin Schneider; Kristian Udosic; Katja Schwenzer-Zimmerer; Nikolaos A Papadopulos; Edgar Biemer
Journal:  Ann Plast Surg       Date:  2006-12       Impact factor: 1.539

5.  First trimester three-dimensional ultrasound volumetry of the gestational sac.

Authors:  H Steiner; A R Gregg; G Bogner; A H Graf; C P Weiner; A Staudach
Journal:  Arch Gynecol Obstet       Date:  1994       Impact factor: 2.344

6.  Cardiovascular function before, during, and after the first and subsequent pregnancies.

Authors:  J F Clapp; E Capeless
Journal:  Am J Cardiol       Date:  1997-12-01       Impact factor: 2.778

7.  Fetal position and size data for dose estimation.

Authors:  E K Osei; K Faulkner
Journal:  Br J Radiol       Date:  1999-04       Impact factor: 3.039

8.  Ventilation during rest and exercise in pregnancy and postpartum.

Authors:  M L Pernoll; J Metcalfe; P A Kovach; R Wachtel; M J Dunham
Journal:  Respir Physiol       Date:  1975-12

9.  Composition of gestational weight gain impacts maternal fat retention and infant birth weight.

Authors:  Nancy F Butte; Kenneth J Ellis; William W Wong; Judy M Hopkinson; E O'Brian Smith
Journal:  Am J Obstet Gynecol       Date:  2003-11       Impact factor: 8.661

10.  Gallbladder motility change in late pregnancy and after delivery.

Authors:  J S Hahm; J Y Park; S C Song; Y J Cho; K H Moon; Y H Song; O Y Lee; H S Choi; B C Yoon; M H Lee; C S Kee; K N Park
Journal:  Korean J Intern Med       Date:  1997-01       Impact factor: 2.884

View more
  107 in total

1.  A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4.

Authors:  Lu Gaohua; Khaled Abduljalil; Masoud Jamei; Trevor N Johnson; Amin Rostami-Hodjegan
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

Review 2.  Gestation-Specific Changes in the Anatomy and Physiology of Healthy Pregnant Women: An Extended Repository of Model Parameters for Physiologically Based Pharmacokinetic Modeling in Pregnancy.

Authors:  André Dallmann; Ibrahim Ince; Michaela Meyer; Stefan Willmann; Thomas Eissing; Georg Hempel
Journal:  Clin Pharmacokinet       Date:  2017-11       Impact factor: 6.447

3.  Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19.

Authors:  Alice Ban Ke; Srikanth C Nallani; Ping Zhao; Amin Rostami-Hodjegan; Jashvant D Unadkat
Journal:  Br J Clin Pharmacol       Date:  2014-03       Impact factor: 4.335

4.  Effect of Pregnancy on Unbound Raltegravir Concentrations in the ANRS 160 RalFe Trial.

Authors:  Yi Zheng; Déborah Hirt; Sandrine Delmas; Gabrielle Lui; Sihem Benaboud; Jerome Lechedanec; Jean-Marc Tréluyer; Camille Chenevier-Gobeaux; Elisa Arezes; Ambre Gelley; Imane Amri; Saïk Urien; Naïm Bouazza; Frantz Foissac; Josiane Warszawski; Jade Ghosn
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

5.  Fetal Physiologically Based Pharmacokinetic Models: Systems Information on Fetal Cardiac Output and Its Distribution to Different Organs during Development.

Authors:  Khaled Abduljalil; Xian Pan; Ruth Clayton; Trevor N Johnson; Masoud Jamei
Journal:  Clin Pharmacokinet       Date:  2021-01-24       Impact factor: 6.447

6.  Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model I: Insights into Factors that Determine Fetal Drug Exposure through Simulations and Sensitivity Analyses.

Authors:  Zufei Zhang; Marjorie Z Imperial; Gabriela I Patilea-Vrana; Janak Wedagedera; Lu Gaohua; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2017-06-06       Impact factor: 3.922

7.  Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model II: Verification of the model for passive placental permeability drugs.

Authors:  Zufei Zhang; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2017-01-03       Impact factor: 3.922

Review 8.  Fetal Physiologically Based Pharmacokinetic Models: Systems Information on the Growth and Composition of Fetal Organs.

Authors:  Khaled Abduljalil; Masoud Jamei; Trevor N Johnson
Journal:  Clin Pharmacokinet       Date:  2019-02       Impact factor: 6.447

9.  Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes?

Authors:  Nina Isoherranen; Kenneth E Thummel
Journal:  Drug Metab Dispos       Date:  2013-02       Impact factor: 3.922

Review 10.  Pharmacokinetic studies in pregnancy.

Authors:  Michael J Avram
Journal:  Semin Perinatol       Date:  2020-01-27       Impact factor: 3.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.